Gene · 9507
Papers2,479
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,261 to 1,280 of 2,479
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of genetic variants associated with skeletal muscle function deficit in childhood acute lymphoblastic leukemia survivors. | Pharmgenomics Pers Med | 2019 | 31114288 | PubTator, text mining | PubMed |
| The Effect of Mesenchymal Stem Cell Wharton's Jelly on ADAMTS-4 and iNOS Levels in Osteoarthritis Rat Model. | Open Access Maced J Med Sci | 2019 | 31110568 | PubTator, text mining | PubMed |
| Inhibition of P2Y11R ameliorated TNF-α-induced degradation of extracellular matrix in human chondrocytic SW1353 cells. | Am J Transl Res | 2019 | 31105822 | PubTator, text mining | PubMed |
| Thrombin-cleaved syndecan-3/-4 ectodomain fragments mediate endothelial barrier dysfunction. | PLoS One | 2019 | 31091226 | PubTator, text mining | PubMed |
| IgE-mediated mast cell activation promotes inflammation and cartilage destruction in osteoarthritis. | Elife | 2019 | 31084709 | PubTator, text mining | PubMed |
| Activation of G-protein-coupled bile acid receptor Gpbar1 (TGR5) inhibits degradation of type II collagen and aggrecan in human chondrocytes. | Eur J Pharmacol | 2019 | 31075239 | PubTator, text mining | PubMed |
| TGF-β type 2 receptor-mediated modulation of the IL-36 family can be therapeutically targeted in osteoarthritis. | Sci Transl Med | 2019 | 31068441 | PubTator, text mining | PubMed |
| IL-1β Damages Fibrocartilage and Upregulates MMP-13 Expression in Fibrochondrocytes in the Condyle of the Temporomandibular Joint. | Int J Mol Sci | 2019 | 31067826 | PubTator, text mining | PubMed |
| Histopathologic and immunohistochemical investigations of dental abscess formed in maxillofacial area. | Folia Morphol (Warsz) | 2019 | 31063202 | PubTator, text mining | PubMed |
| MicroRNA-125b-5p regulates IL-1β induced inflammatory genes via targeting TRAF6-mediated MAPKs and NF-κB signaling in human osteoarthritic chondrocytes. | Sci Rep | 2019 | 31053727 | PubTator, text mining | PubMed |
| Molecular Relationships among Obesity, Inflammation and Intervertebral Disc Degeneration: Are Adipokines the Common Link? | Int J Mol Sci | 2019 | 31027158 | PubTator, text mining | PubMed |
| The role of sirtuin 1 and its activator, resveratrol in osteoarthritis. | Biosci Rep | 2019 | 30996115 | PubTator, text mining | PubMed |
| Pro-atherogenic proteoglycanase ADAMTS-1 is down-regulated by lauric acid through PI3K and JNK signaling pathways in THP-1 derived macrophages. | Mol Biol Rep | 2019 | 30989556 | PubTator, text mining | PubMed |
Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study. | Biosci Rep | 2019 | 30988064 | PubTator, text mining | PubMed |
| Neurocan is a New Substrate for the ADAMTS12 Metalloprotease: Potential Implications in Neuropathies. | Cell Physiol Biochem | 2019 | 30977985 | PubTator, text mining | PubMed |
| Expression and Activity of TRPA1 and TRPV1 in the Intervertebral Disc: Association with Inflammation and Matrix Remodeling. | Int J Mol Sci | 2019 | 30974795 | PubTator, text mining | PubMed |
| Role of ADAMTS4 and ADAMTS5 during early orthodontic tooth movement. | J Biol Regul Homeost Agents | 2019 | 30968682 | PubTator, text mining | PubMed |
| Resveratrol attenuates inflammation environment-induced nucleus pulposus cell senescence in vitro. | Biosci Rep | 2019 | 30962260 | PubTator, text mining | PubMed |
| Platelet-Rich Fibrin Scaffolds for Cartilage and Tendon Regenerative Medicine: From Bench to Bedside. | Int J Mol Sci | 2019 | 30959772 | PubTator, text mining | PubMed |
| MicroRNA-134-5p Regulates Media Degeneration through Inhibiting VSMC Phenotypic Switch and Migration in Thoracic Aortic Dissection. | Mol Ther Nucleic Acids | 2019 | 30951965 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9507/papers?page=64